# Brink's (BCO) — Financial Analysis

**Exchange:**   
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-10  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/bco/thesis · /memo/bco

## Financial Snapshot

---
source: coverage-next-full
ticker: BCO
step: 04
title: Financial Quality & Adversarial Sweep
date: 2026-06-10
---

### Step 04 — Financial Quality: Brink's Company (BCO)

#### Statement Quality Assessment

##### Income Statement Quality

**Key adjustments and concerns:**

| Item | GAAP Treatment | Non-GAAP Add-Back | Quality Flag |
|------|---------------|-------------------|-------------|
| Acquisition amortization | Expense | Yes — ~$150–200M/yr | MEDIUM: G4S + NCR Atleos intangibles will persist for 10–20 years post-close |
| Restructuring charges | Expense | Yes — ~$50–80M/yr | MEDIUM: "Recurring" restructuring charges over multiple years raise questions about what is truly one-time |
| Stock-based compensation | Expense | No (Non-GAAP includes SBC) | LOW: SBC is ~$60–80M/yr; real dilution cost |
| Argentina hyperinflation | FX adjustment | N/A | MEDIUM: Affects revenue/income; use organic metrics |
| Tax rate volatility | Variable ~25–35% | No | LOW-MEDIUM: Rate has been volatile; watch effective tax rate |

**Key finding:** The $3.35/share GAAP-to-Non-GAAP EPS gap is persistent, not one-time. Post-NCR Atleos, this gap will likely widen further as new amortization layers on. Investors should use both metrics: Non-GAAP for operational trend analysis, GAAP for absolute value anchoring. **[S1]**

##### Balance Sheet Quality

| Metric | FY2025 | FY2024 | FY2023 | Trend |
|--------|--------|--------|--------|-------|
| Total Assets | ~$7.5B | ~$7.2B | ~$7.0B | Growing |
| Goodwill + Intangibles | ~$3.0–3.5B | ~$3.2B | ~$3.3B | Elevated (G4S) |
| Goodwill/Total Assets | ~40–47% | ~44% | ~47% | Watch |
| Total Debt | ~$4.5B | ~$4.3B | ~$4.0B | Elevated |
| Cash & Equivalents | ~$1.6B | ~$1.5B | ~$1.4B | Adequate |
| Net Debt | ~$2.9B | ~$2.8B | ~$2.6B | Elevated |
| Common Equity (book) | ~$278M | ~$250M | ~$240M | Very thin |
| Debt/Adj.EBITDA | ~5.1x | ~4.7x | ~4.6x | Above comfort |

**Balance sheet flags:**
- **Goodwill concentration:** ~40–47% of total assets is goodwill/intangibles from acquisitions. Any impairment test failure would be material.
- **Very thin book equity (~$278M):** The company's book equity is minimal relative to enterprise value. Share buybacks have consumed book equity; tangible book value is negative.
- **Leverage:** Debt/EBITDA at 5.1x is above investment-grade comfort (typically ≤3.5x). BCO's credit rating is sub-investment-grade (BB range). **[S2]**

##### Cash Flow Quality

| Metric | FY2025 | FY2024 | FY2023 | Quality |
|--------|--------|--------|--------|---------|
| Operating Cash Flow | $640M | ~$560M | ~$702M | HIGH — record in FY2025 |
| Capex | ~$203M | ~$195M | ~$180M | Normal range |
| Free Cash Flow | ~$436M | ~$400M | ~$350M | Improving |
| FCF/Adj.EBITDA | ~44.6% | ~43.9% | ~40.4% | STRONG |
| FCF/Net Income (GAAP) | ~220% | ~210% | ~230% | Excellent cash conversion |

**Cash flow quality is HIGH.** Despite thin GAAP earnings, operating cash flow is strong and improving. FCF/Adj.EBITDA of ~44–45% is at the top end of management's 40–45% target. The high FCF-to-GAAP-net-income conversion ratio (2x+) reflects the non-cash nature of most adjustments (amortization, restructuring non-cash components). This is genuinely good cash generation. **[S3]**

#### Adjusted Financial Metrics

For analytical purposes (and for `/complete-coverage` valuation):

| Metric | FY2025A | FY2024A | FY2023A |
|--------|---------|---------|---------|
| Revenue | $5,261M | $5,012M | $4,784M |
| Adj. EBITDA | $977M | $912M | $867M |
| Adj. EBITDA Margin | 18.6% | 18.2% | 18.1% |
| GAAP EPS | $4.70 | ~$3.56 | ~$2.81 |
| Non-GAAP EPS | $8.05 | ~$7.10 | ~$6.30 |
| FCF | ~$436M | ~$400M | ~$350M |
| FCF/Share | ~$10.50 | ~$9.50 | ~$8.20 |

---

#### Adversarial Research Sweep

*This section documents material negative signals, controversies, litigation, and short-seller theses that a rigorous analyst must investigate.*

##### 1. Short Interest / Short Reports

- **Status:** No major short-seller reports identified from Hindenburg, Muddy Waters, or similar firms targeting BCO specifically. **[S4]**
- Short interest: ~3–5% of float (relatively modest; not a heavily shorted name)
- BCO is not on prominent "short watchlists" for accounting fraud concerns

**Conclusion:** No credible short-seller fraud allegations requiring further investigation.

##### 2. Argentina / Hyperinflation Accounting

- BCO operates in Argentina, which is classified as a hyperinflationary economy under US GAAP (ASC 830-10-45-11). This requires special accounting treatment.
- The Argentine peso has lost 80–90% of its value against the USD over 2022–2025.
- **Impact:** Argentina-related adjustments can swing reported revenue by hundreds of millions; organic growth metrics strip this out.
- **Risk:** If Argentina operations deteriorate further, or if BCO writes down Argentine assets, it could impact GAAP results materially.
- **Mitigation:** Management and analysts focus on organic growth metrics; Argentina is flagged consistently in filings. **[S1]**

**Conclusion:** Known risk, well-disclosed, manageable. Monitor.

##### 3. Litigation / Legal Exposures

- **Workplace injuries:** Armored car guard injuries and robberies are ongoing litigation risks. Several incidents documented in 10-K risk factors.
- **Competition investigations:** Some jurisdictions have investigated pricing practices in the cash logistics industry (EU and LatAm); no active material BCO-specific proceedings found.
- **Labor disputes:** Periodic union disputes in Europe and Latin America; have caused service disruptions but not material financial harm historically.
- **Status:** 10-K FY2024 discloses routine litigation but no material pending judgments. **[S1]**

**Conclusion:** Low-medium risk. Typical for an industrial services company with a large workforce.

##### 4. NCR Atleos Acquisition Risk (Feb 2026)

- **Size:** $6.6B enterprise value for a ~$2B revenue company (~3.3x revenue; ~8–10x EBITDA depending on margins) is a significant premium.
- **Financing risk:** BCO must raise $6B+ in new debt; credit market conditions at deal close will determine terms.
- **Integration risk:** BCO is still integrating G4S Cash (acquired 2020); layering NCR Atleos is an ambitious undertaking.
- **Regulatory risk:** ATM market concentration may attract antitrust scrutiny in certain geographies.
- **Leverage spike:** Pro-forma Net Debt/EBITDA post-deal likely spikes to 7–9x before synergy-driven deleveraging.

**This is the single largest risk in the BCO thesis.** Management's 35%+ EPS accretion / $200M+ synergies claims are ambitious and not yet proven. **[S5]**

**Conclusion:** HIGH risk; this is the primary bear case catalyst. Must be modeled explicitly in scenarios.

##### 5. Debt Maturity and Refinancing Risk

- BCO has ~$4.5B in debt; significant maturities need refinancing over the 2025–2027 period.
- Current rates (5–7% on senior secured) are significantly higher than the low-rate era when some debt was issued.
- Credit rating: BB/Ba range (sub-investment grade) — faces higher borrowing costs than investment-grade peers.
- Post-NCR Atleos, leverage will spike; maintaining covenants becomes critical.

**Conclusion:** Elevated risk, particularly if credit markets tighten around NCR Atleos close. **[S2]**

##### 6. Cash-Use Secular Decline

- Long-term structural risk: physical cash use declining in developed markets (UK, Nordics most advanced; US slower)
- BCO's CVS segment (76% of revenue) is most exposed
- AMS/DRS pivot is the response; but transition execution risk is real

**Conclusion:** Known, well-discounted secular risk. BCO is actively managing this. **[S6]**

#### Financial Quality Summary

| Dimension | Score | Notes |
|-----------|-------|-------|
| Revenue quality | 8/10 | Recurring contracts, diversified |
| Earnings quality (GAAP) | 5/10 | Large non-cash charges; thin GAAP margins |
| Cash flow quality | 9/10 | Strong FCF, high conversion |
| Balance sheet quality | 5/10 | High leverage, thin equity, goodwill-heavy |
| Disclosure quality | 7/10 | Segment detail good; Non-GAAP heavy |
| Fraud/accounting risk | Low | No credible concerns identified |

#### Source Index

| ID | Source | Detail |
|----|--------|--------|
| S1 | SEC 10-K FY2024 + FY2023 | Financial statements, risk factors, Argentina |
| S2 | StockAnalysis.com | Leverage ratios, debt metrics |
| S3 | Brink's FY2025 earnings release | OCF, FCF, record results |
| S4 | Tavily web search | Short seller reports, controversy search |
| S5 | NCR Atleos acquisition press release | Transaction terms, risk factors |
| S6 | Industry overview | Cash displacement trend |

---

**Thesis tracker update (Step 04):** Cash flow quality is the underappreciated strength of this story — $436M FCF on a $4.2B market cap is a ~10.4% FCF yield, which is exceptional if sustainable. The NCR Atleos acquisition is the single biggest risk: it will spike leverage to 7–9x and requires flawless integration. The GAAP-to-Non-GAAP gap is persistent but explainable (acquisition amortization). No accounting fraud concerns.

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/BCO/fundamental

## Navigation

- Overview: /stocks/bco
- Financials (this page): /stocks/bco/financials
- Thesis: /stocks/bco/thesis
- Investment Memo: /memo/bco
- Coverage universe: /stocks